Forma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FMTX and buy or sell other stocks, ETFs, and their options commission-free!About FMTX
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer.
CEOFrank D. Lee, MBA
CEOFrank D. Lee, MBA
Employees—
Employees—
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
FMTX Key Statistics
Market cap957.53M
Market cap957.53M
Price-Earnings ratio-5.00
Price-Earnings ratio-5.00
Dividend yield—
Dividend yield—
Average volume710.37K
Average volume710.37K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.68
52 Week high$20.68
52 Week low$4.95
52 Week low$4.95
Stock Snapshot
With a market cap of 957.53M, Forma Therapeutics(FMTX) trades at $20.01. The stock has a price-to-earnings ratio of -5.00.
During the trading day, Forma Therapeutics(FMTX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 710.37K.
Over the past 52 weeks, Forma Therapeutics(FMTX) stock has traded between a high of $20.68 and a low of $4.95.
Over the past 52 weeks, Forma Therapeutics(FMTX) stock has traded between a high of $20.68 and a low of $4.95.
People also own
Based on the portfolios of people who own FMTX. This list is generated using Robinhood data, and it’s not a recommendation.